GEXVal CEO Speaks at CPHI Japan 2024
wpmaster
GEXVal Inc.
April 12, 2024
Juran Kato, PhD, President and CEO of GEXVal Inc., will be a speaker at the Drug Discovery Innovation Seminar during CPHI Japan 2024 to be held at Tokyo Big Sight from April 17 to 19. CPHI Japan is an international event organized by Informa Markets Japan K.K., covering the entire pharmaceutical industry value chain, from drug discovery to manufacturing. The Drug Discovery Innovation Seminar aims to promote innovation and development of new drugs from Japan. Amongst other pioneers in the pharmaceutical industry and academia, Dr. Kato was invited as a speaker at the event.
◇Seminar
Drug Discovery Innovation Seminar (Pre-registration required)
- Date and time : April 19 at 3:30 p.m.
- Venue : 4C (in East Hall 4)
Purposed to Repurpose ®
~Innovation to Generate Extra Value for Rare Diseases~
https://www.informa-japan.com/cphifcj/seminar/en/index.php?category=104
Event detail
CPHI Japan 2024
- Date and Time: April 17-19, 2024 (Pre-registration required)
At the heart of Pharma | CPHI Japan - Location: East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
Leave No One Behind. GEXVal is a member of the “Regional Revitalization SDGs Public-Private Partnership Platform”, sponsored by the Cabinet office of Japan. For one of the 17 SDGs’ goal “Good Health and Well-being”, GEXVal tackles “Access to Medicine” issues in rare and untreatable diseases. We strive to deliver cost-effective, innovative treatment options to improve QoL of patients and families who are waiting for better treatment options.
For further information: info@gexval.com
